Investments made by Yourgene Health (LON: YGEN) will start to pay off this year, which will include a full 12-month contribution from the US business acquired last year.
The first quarter of the current financial year has started strongly, and Yourgene Health is on course to move into profit this year.
Yourgene Health is an international molecular diagnostics business offering genomics technology and services. The acquisition of Coastal Genomics Inc provides a strong base in the US which is yet to be fully exploited.
Non-invasive parental tests (NIPT) for Down’s Syndrome and other po...
